Insider Transactions in Q1 2021 at Orchard Therapeutics PLC (ORTX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 19
2021
|
Fmr LLC > 10% Shareholder |
SELL
Conversion of derivative security
|
Indirect |
819,704
-9.09%
|
-
|
|
Feb 05
2021
|
Fmr LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,045,510
-16.71%
|
$12,273,060
$6.98 P/Share
|
|
Jan 29
2021
|
Frank E Thomas |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+19.2%
|
$20,000
$2.44 P/Share
|
|
Jan 11
2021
|
Bobby Gaspar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,411
-0.96%
|
$20,466
$6.72 P/Share
|
|
Jan 11
2021
|
Frank E Thomas |
SELL
Payment of exercise price or tax liability
|
Direct |
3,706
-10.36%
|
$22,236
$6.72 P/Share
|
|
Jan 08
2021
|
Bobby Gaspar Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+1.73%
|
-
|
|
Jan 08
2021
|
Frank E Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
10,667
+22.96%
|
-
|